Skip to content

DCH DCH Restructuring and acquisition-related costs

Restructuring and acquisition-related costs at other companies

Novanta logo
NovantaNOVT
$2.61M+206%
Hayward Holdings logo
Hayward HoldingsHAYW
$505K-73.8%
ICU Medical logo
ICU MedicalICUI
$16.63M+11.1%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$4.4M-72.7%
Leidos Holdings logo
Leidos HoldingsLDOS
$35M+775%
Hillman Solutions Corp. logo
Hillman Solutions Corp.HLMN
$1.01M+36.3%

Other financials

Income statement

See full
Revenue$2.4B+68.6%
Gross profit$225.4M+29.6%
Operating income-$33.7M-179%
Net income-$100.3M-1,513%
EPS (diluted)-$0.52-967%

Balance sheet

See full
Cash & equivalents$1.0B+83.6%
Total debt$5.4B+95.8%
Total equity$1.5B+151%
Total assets$11.3B+119%

Cash flow

See full
Operating cash flow-$64.4M-215%
CapEx$103.6M+49.5%
Free cash flow-$168.0M-1,154%

Valuation

See full
Market cap$1.32B
Enterprise value$5.75B
P/S0.2×

Profitability

See full
Gross margin11.1%-1.0pp
Operating margin3.1%-0.6pp
Net margin-1.9%
FCF margin0%-3.8pp

Returns & leverage

See full
Return on equity-12.1%
Debt / equity3.6×-1.0×
Current ratio1.4×-0.3×

Where this comes from

Reported directly by DCH in its filing.

Tagged under the XBRL concept dch:Restructuringandacquisitionrelatedcosts.

The official record: DCH’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about DCH's restructuring and acquisition-related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DCH's restructuring and acquisition-related costs?
DCH (DCH) reported restructuring and acquisition-related costs of $98.9M in Q1 2026.
How has DCH's restructuring and acquisition-related costs changed year-over-year?
DCH's restructuring and acquisition-related costs increased by 402.0% year-over-year, from $19.7M to $98.9M.
What does restructuring and acquisition-related costs mean?
Includes expenses incurred during organizational restructuring, workforce reductions, or the integration of acquired businesses. These costs reflect the financial burden of transforming the company's operational structure or scaling through inorganic growth. Tracking these expenses helps investors evaluate the efficiency of management's integration strategies and the long-term cost-benefit of corporate transformations.